Tandem Diabetes Care (TNDM): Undervalued Technology Leader
Tandem Diabetes Care has fallen over 70% YTD for several reasons. Click here to read why I rate TNDM stock a strong buy on turnaround potential in 2023.
Source: seekingalpha.com
Stay updated with breaking news from Paul Strasma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tandem Diabetes Care has fallen over 70% YTD for several reasons. Click here to read why I rate TNDM stock a strong buy on turnaround potential in 2023.